Page 23 - Imaging Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

 E-Mail An open-source platform, OpenEP co-developed by researchers from the School of Biomedical Engineering & Imaging Sciences at King's College London has been made available to advance research on atrial fibrillation, a condition characterised by an irregular and often fast heartbeat. It can cause significant symptoms such as breathlessness, palpitations and fatigue, as well as being a major contributor to stroke and heart failure. Current research into the condition involves the interpretation of large amounts of clinical patient data using software written by individual research grou...

Blue Earth Diagnostics Announces Dosing of Initial Patient in Phase 3 REVELATE Clinical Trial of 18F-Fluciclovine PET Imaging for Detection of Recurrent Brain Metastases Clinical utility of Axumin (fluciclovine F 18) being investigated in expanded areas of cancer imaging Getty Images January 18, 2021 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced that the first patient has been dosed in its Phase 3 REVELATE clinical trial of 18F-fluciclovine, a positron emission tomography...

New Algorithm Mimics Electrosensing In Fish - 7:33 pm Weakly electric fish are specially adapted to traverse obscured waters without relying on vision; instead, they sense their environment via electric fields. Courtesy/SIAM SIAM News: While humans may struggle to navigate a murky, turbid underwater environment, weakly electric fish can do so with ease. These aquatic animals are specially adapted to traverse obscured waters without relying on vision; instead, they sense their environment via electric fields. Now, researchers are attempting to adapt these electrosensing ...

(1) - Clinical utility of Axumin (fluciclovine F 18) being investigated in expanded areas of cancer imaging - Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced that the first patient has been dosed in its Phase 3 REVELATE clinical trial of 18F-fluciclovine, a positron emission tomography (PET) imaging radiopharmaceutical being studied for potential use in detecting recurrent brain metastases. The REVELATE study is a Phase 3, multi-center, single-arm imaging study being conducted in t...

Dr Lakdawala clears the air on allegations made by Eman Ahmed's sister Dr Lakdawala clears the air on allegations made by Eman Ahmed's sister Egyptian National Eman Ahmed, The Heaviest Woman Recently Got Operated But Now Her Sister Is Blaming The Doctors That The Operation Had Some Loopholes. Dr Muffazal Lakdawala, Who Is Treating Her, On Wednesday Said “truth Shall Eventually Prevail. PTI | Updated on: 26 Apr 2017, 08:36:11 AM Mumbai: Egyptian national Eman Ahmed, the heaviest woman recently got operated but now her sister is blaming the doctors that the ...